Trademark Overview
On Monday, December 8, 2025, a trademark application was filed for BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE with the United States Patent and Trademark Office. The USPTO has given the BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE trademark a serial number of 99536726. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 8, 2025. This trademark is owned by Zhuhai Beihai Biotech Co., Ltd.. The BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE trademark is filed in the Pharmaceutical Products category with the following description:
Analgesics; Antiemetics; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Chemical reagents for medical purposes; Medicinal infusions for treating cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines made of Chinese traditional medicinal herbs; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the treatment of cancer; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
